ADOREYES Proudly Partners with the Aerolase Skin Health Summit Toronto 2026

ADOREYES was honoured to participate as a proud partner of the Aerolase Skin Health Summit Toronto 2026, joining leading physicians, nurses, dermatology professionals, and medical aesthetic practitioners from across Canada for a day dedicated to advancing skin health and aesthetic medicine.

Hosted at Hotel X Toronto, the summit brought together industry experts to explore the latest innovations, treatment protocols, and technologies shaping the future of skin health. The event provided a valuable opportunity for collaboration, education, and meaningful discussions focused on improving patient outcomes through science-backed solutions.

As a partner of the summit, ADOREYES showcased ExoScript MD™, our clinic-exclusive dual exosome technology developed to support skin recovery, hydration, and visible rejuvenation following aesthetic procedures. Attendees had the opportunity to visit the ADOREYES Skin Health Lab, connect with our team, and learn more about the research and innovation behind our latest advancements in regenerative skincare.

ExoScript MD™ combines Lactobacillus-derived extracellular vesicles and proprietary grape-derived extracellular vesicles with biomimetic peptides, growth factor-inspired technologies, hyaluronic acid, and barrier-supporting lipids. The result is a comprehensive professional solution designed to complement procedures such as laser treatments, microneedling, and radiofrequency therapies while supporting the skin’s natural renewal processes.

The Aerolase Skin Health Summit highlighted the growing demand for evidence-based technologies and integrated treatment approaches within medical aesthetics. We were inspired by the knowledge shared by industry leaders and by the commitment of practitioners who continuously seek innovative ways to elevate patient care.

As a Canadian company focused on research, innovation, and professional education, ADOREYES remains committed to developing advanced skincare technologies that help practitioners deliver exceptional treatment experiences and visible results.

We extend our sincere thanks to the Aerolase team, event organizers, speakers, and attendees for creating such a memorable and impactful event. We look forward to continuing to support the medical aesthetic community and advancing the future of skin health together.

Clinics interested in learning more about combining ExoScript MD™ Dual Exosome Technology with Aerolase Neo Elite® and Era Elite® treatments are invited to connect with our team. We would be pleased to share clinical protocols, treatment integration strategies, and post-procedure recommendations designed to help maximize patient outcomes and elevate the treatment experience.